RNA polymerase III transcription is repressed in response to the tumour suppressor ARF

Jennifer P. Morton, Theodoros Kantidakis, Robert J. White*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

The tumour suppressor protein ARF provides a defence mechanism against hyperproliferative stresses that can result from the aberrant activation of oncogenes. Accordingly, ARF is silenced or deleted in many human cancers. Activation of ARF can arrest growth and cell cycle progression, or trigger apoptosis. A principle mediator of these effects is p53, which ARF stabilizes by binding and inhibiting MDM2. However, ARF has additional targets and remains able to block growth in the absence of p53, albeit less efficiently. For example, ARF can suppress rRNA production in a p53-independent manner. We have found that the synthesis of tRNA by RNA polymerase III is also inhibited in response to ARF. However, in contrast to its effects on rRNA synthesis, ARF is unable to inhibit tRNA gene transcription when p53 is ablated. These results add to the growing list of cellular changes that can be triggered by ARF induction.

Original languageEnglish
Pages (from-to)3046-3052
Number of pages7
JournalNucleic Acids Research
Volume35
Issue number9
DOIs
Publication statusPublished - 1 May 2007

Bibliographical note

© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Fingerprint Dive into the research topics of 'RNA polymerase III transcription is repressed in response to the tumour suppressor ARF'. Together they form a unique fingerprint.

  • Cite this